Quantbot Technologies’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-80,079
Closed -$2M 2177
2026
Q1
$2M Buy
80,079
+33,577
+72% +$946K 0.08% 376
2025
Q4
$1.46M Buy
46,502
+35,994
+343% +$1.19M 0.05% 551
2025
Q3
$375K Sell
10,508
-661
-6% -$30.2K 0.01% 1125
2025
Q2
$643K Sell
11,169
-9,177
-45% -$519K 0.02% 927
2025
Q1
$1.19M Sell
20,346
-18,673
-48% -$1.27M 0.04% 619
2024
Q4
$3.14M Buy
39,019
+19,742
+102% +$1.69M 0.11% 263
2024
Q3
$1.54M Sell
19,277
-11,612
-38% -$825K 0.06% 482
2024
Q2
$1.89M Buy
30,889
+315
+1% +$18.7K 0.09% 337
2024
Q1
$1.51M Buy
30,574
+18,437
+152% +$878K 0.09% 368
2023
Q4
$509K Buy
+12,137
New +$413K 0.03% 727
2023
Q1
Sell
-18,098
Closed -$752K 1958
2022
Q4
$752K Buy
18,098
+9,154
+102% +$393K 0.05% 456
2022
Q3
$370K Buy
8,944
+3,478
+64% +$139K 0.03% 675
2022
Q2
$178K Buy
+5,466
New +$199K 0.02% 963

Other funds holding PRCT

Quantbot Technologies's PRCT Position: Q2 2026 in Review

Quantbot Technologies sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 80,079 shares — an estimated $2M sold.

Quantbot Technologies first reported a position in PRCT in Q2 2022 and held it in 13 quarters. The position peaked at $3.14M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Quantbot Technologies reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 80,079 Procept Biorobotics shares in Q2 2026, an estimated $2M.
  • Quantbot Technologies first reported a position in Procept Biorobotics in Q2 2022 and held it in 13 quarters.
  • Quantbot Technologies's Procept Biorobotics position peaked at $3.14M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.